Assessment of the cardiac safety between cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory mCRC

OBJECTIVE: The cardiac safety of cetuximab and panitumumab, particularly as single agents, has not been investigated extensively. This trial was designed to specifically evaluate the cardiac safety of cetuximab and panitumumab as single therapy in Chinese chemotherapy-refractory metastatic colorecta...

Celý popis

Podrobná bibliografie
Hlavní autoři: Tang, Xue-miao, Chen, Hao, Li, Qing, Song, Yiling, Zhang, Shuping, Xu, Xiao-Shuan, Xu, Yiwei, Chen, Shulin
Médium: Online Článek Text
Jazyk:English
Vydáno: Dove Medical Press 2017
Témata:
Original Research
On-line přístup:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749385/
https://www.ncbi.nlm.nih.gov/pubmed/29343971
http://dx.doi.org/10.2147/OTT.S149716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749385/
https://www.ncbi.nlm.nih.gov/pubmed/29343971
http://dx.doi.org/10.2147/OTT.S149716

Podobné jednotky